Abbvie Inc’s recently made public that its Officer GONZALEZ RICHARD A acquired Company’s shares for reported $1.3 million on Mar 03 ’25. In the deal valued at $210.53 per share,6,168 shares were bought.
Then, PERRY C SIATIS bought 18,008 shares, generating $3,781,680 in total proceeds.
Before that, TIMOTHY RICHMOND bought 21,250 shares. Abbvie Inc shares valued at $4,472,184 were divested by the Officer at a price of $210.46 per share.
A number of analysts have revised their coverage, including Daiwa Securities’s analysts, who decreased its forecast for the stock in early December from “an Outperform” to “a Neutral”. Leerink Partners also remained covering ABBV and has increased its forecast on November 22, 2024 with a “an Outperform” recommendation from previously “Market perform” rating. Wolfe Research started covering the stock on November 15, 2024. It rated ABBV as “an Outperform”.
Price Performance Review of ABBV
On Monday, Abbvie Inc [NYSE:ABBV] saw its stock jump 1.17% to $211.48. Over the last five days, the stock has gained 3.63%. Abbvie Inc shares have risen nearly 19.01% since the year began. Nevertheless, the stocks have risen 18.81% over the past one year. While a 52-week high of $209.60 was reached on 03/03/25, a 52-week low of $153.58 was recorded on 01/22/25. SMA at 50 days reached $184.55, while 200 days put it at $182.32.
Levels Of Support And Resistance For ABBV Stock
The 24-hour chart illustrates a support level at 209.49, which if violated will result in even more drops to 207.51. On the upside, there is a resistance level at 212.88. A further resistance level may holdings at 214.29. The Relative Strength Index (RSI) on the 14-day chart is 82.37, which indicates overbought technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 8.19, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 3.41%. Stochastics %K at 94.77% indicates the stock is a selling.
